ÌÇÐÄvlog

[Skip to Navigation]
Sign In
Viewpoint
February 8, 2023

Double Standards and Inconsistencies in Access to Care—What Constitutes a Cosmetic Treatment?

Author Affiliations
  • 1Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts
  • 2Associate Editor, JAMA Dermatology
  • 3Division of Dermatology, Department of Medicine, John H. Stroger Jr Hospital of Cook County, Chicago, Illinois
  • 4Department of Medicine, Rush Medical College, Chicago, Illinois
JAMA Dermatol. 2023;159(3):245-246. doi:10.1001/jamadermatol.2022.6322

Dermatologists have a wide scope of practice; given that they provide medical, surgical, and cosmetic services, it is important to consider what distinguishes medically necessary care from cosmetic treatments. This issue is particularly important as payers may be less likely to provide medical coverage for conditions that are viewed as cosmetic.

Current paradigms highlight a lack of consistency with regard to what constitutes a cosmetic treatment. In 2016, the 21st Century Cures Act1 amended the Social Security Act paragraph 1903, section 21 to forbid payment of treatments for cosmetic purposes or hair growth—except where medically necessary. There is a trend for Centers for Medicare & Medicaid Services (CMS) and other payers to consider treatment of skin disease to be medically necessary when it is associated with a disturbance of sensation (eg, itch, pain) but not when the primary effects are psychosocial (eg, depression, stigma, social isolation).

Add or change institution
1 Comment for this article
EXPAND ALL
Socially Meaningful Dermatology
Ajit P, MBBS, DDV | Research Associate, Pediatric Dermatology, B J Wadia Hospital for Children Mumbai, India
Read Double Standards and Inconsistencies in Access to Care—What Constitutes a Cosmetic Treatment?(1) Skin is more than a protective shield against external assaults. Skin is an important organ of emotional expression, what may be called the social skin in contrast to biologic skin. People with heart disease and cancer get sympathy, but those with skin disease might be greeted with revulsion.(2) Paradigms like the behavioral immune system need to be factored in while tackling stigma related to skin diseases. Briefly, it is an evolutionarily developed suite of behavioral responses designed to avoid contracting an infection, since launching an immune response is costly ( consumes energy) and is not always successful. These behavioural responses are triggered on perceiving certain cues that signal the presence of pathogens in the environment or other individuals (e.g. sight of faeces, flies, foul smell, putrefaction, skin diseases, physical deformities) leading to avoidance responses towards such cues (e.g. avoiding people who are coughing, sneezing, look dirty, have skin diseases), and also driving more overt, at times aggressive responses against such individuals (discrimination, ridicule, isolation).(3) Hair prostheses and camouflage creams need to be considered mainstream treatments providing symptomatic relief from stigma (treatments for vitiligo and severe alopecia areata take time to work and have poor long term outcome as of now). More studies are needed to eke out the diverse intentions of people seeking cosmetic interventions. Maisel et al. studying motivations for seeking cosmetic treatment found most patients noted looking younger or fresher (83.4%) and having clear skin (81.4%) as motivations.4 More patients wanted to look better, prettier, or more attractive for themselves (88.5%) rather than for others (64.4%). In a subset of patients however the primary motivation was external. For 27.1% of participants however, the primary motivation was to look better for others.(4) It would be interesting to find if some patients view cosmetic treatments as a way of splurging on themselves, thus making such treatments a kind of a Veblen good.(5) For a patient with skin diseases the opinions of others matter. It is important not to be dismissive of the diverse needs of patients seeking cosmetic interventions, whether to avoid stigma or to look pretty. Treatments must be socially meaningful.


References
1. Barbieri JS, LaChance A, Albrecht J. Double Standards and Inconsistencies in Access to Care—What Constitutes a Cosmetic Treatment? JAMA Dermatol. Published online February 08, 2023.

2. Kligman AM, Koblenzer C. Demographics and psychological implications for the aging population. Dermatol Clin. 1997;15(4):549-553.

3. Barve A. The role of the behavioural immune system in stigma related to skin diseases needs to be explored. Clin Exp Dermatol. 2021 Dec;46(8):1662-1664. doi: 10.1111/ced.14750. Epub 2021 Jun 26.

4. Maisel A, Waldman A, Furlan K, Weil A, Sacotte K, Lazaroff JM, Lin K, Aranzazu D, Avram MM, Bell A, Cartee TV, Cazzaniga A, Chapas A, Crispin MK, Croix JA, DiGiorgio CM, Dover JS, Goldberg DJ, Goldman MP, Green JB, Griffin CL, Haimovic AD, Hausauer AK, Hernandez SL, Hsu S, Ibrahim O, Jones DH, Kaufman J, Kilmer SL, Lee NY, McDaniel DH, Schlessinger J, Tanzi E, Weiss ET, Weiss RA, Wu D, Poon E, Alam M. Self-reported Patient Motivations for Seeking Cosmetic Procedures. JAMA Dermatol. 2018 Oct1;154(10):1167-1174

5. Veblen T. The Theory of the Leisure Class: An Economic Study of Institutions. New York, NY: Macmillan; 1899.
CONFLICT OF INTEREST: None Reported
READ MORE
×